Evidence map›Paper›PMID 27863935›Full record

ArticleSchizophrenia research2017

Association of sFlt-1 and worsening psychopathology in relatives at high risk for psychosis: A longitudinal study.

Paulo L Lizano, Jeffrey K Yao, Neeraj Tandon, Suraj Sarvode Mothi, Debra M Montrose, Matcheri S Keshavan

Abstract read
In one paragraph

Article in Schizophrenia research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.9field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 1 country.

Paulo L LizanoDepartment of Psychiatry, Beth Israel Deaconess Medical Center, Boston, MA, United States; Division of Public Psychiatry, Massachusetts Mental Health Center, Boston, MA, United States.
Jeffrey K YaoDepartment of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States; VA Pittsburgh Healthcare System, Medical Research Service, Pittsburgh, PA, United States; Department of Pharmaceutical Sciences, University of Pittsburgh School of Pharmacy, Pittsburgh, PA, United States. Electronic address: jkyao@pitt.edu.
Neeraj TandonDepartment of Psychiatry, Beth Israel Deaconess Medical Center, Boston, MA, United States; Baylor College of Medicine, Houston, TX, United States.
Suraj Sarvode MothiDivision of Public Psychiatry, Massachusetts Mental Health Center, Boston, MA, United States.
Debra M MontroseDepartment of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States.
Matcheri S KeshavanDepartment of Psychiatry, Beth Israel Deaconess Medical Center, Boston, MA, United States; Division of Public Psychiatry, Massachusetts Mental Health Center, Boston, MA, United States; Department of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States; Department of Psychiatry, Harvard Medical School, Boston, MA, United States. Electronic address: mkeshava@bidmc.harvard.edu.
University of Pittsburgh · USBaylor College of Medicine · USBeth Israel Deaconess Medical Center · USMassachusetts Mental Health Center · USVA Pittsburgh Healthcare System · US

Funding

UNIVERSITY OF PITTSBURGH CLINICAL AND TRANSLATIONAL SCIENCE INSTITUTE: BPCAUL1RR024153 · NCRR · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI REIS, STEVEN E · 2006 to 2011
$73.9M
WITHIN SUBJ VARIABILITY IN MEASUREMENTS DRUG METABOL ENZYMES IN HLTY SUBJM01RR000056 · NCRR · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI LEVINE, ARTHUR S · 1985 to 2006
$29.2M
THE ROLE OF PREFRONTAL CORTEX IN THE COGNITIVE DYSFUNCTIONS OF SCHIZOPHRENIAP50MH045156 · NIMH · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI SAMPSON, ALLAN R · 1990 to 2007
$17.9M
Project 5: In vivo measurement of GABA transmission in healthy controls & subjectP50MH084053 · NIMH · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI LEWIS, DAVID A · 2008 to 2012
$11.5M
Brain Maturation and Vulnerability to SchizophreniaR01MH064023 · NIMH · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI KESHAVAN, MATCHERI S. · 2003 to 2008
$3.0M
MEMBRANE DEFICITS AND OUTCOME IN SCHIZOPHRENIAR01MH058141 · NIMH · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI YAO, JEFFREY K · 1999 to 2003
$979k
CORTICAL PRUNING AND SCHIZOPHRENIAK02MH001180 · NIMH · WAYNE STATE UNIVERSITY · PI KESHAVAN, MATCHERI S. · 1995 to 2005
$648k
NCRR NIH HHS M01 RR000056NCRR NIH HHS UL1 RR024153NIMH NIH HHS K02 MH001180NIMH NIH HHS P50 MH045156NIMH NIH HHS P50 MH084053NIMH NIH HHS R01 MH058141NIMH NIH HHS R01 MH064023
6 · The paper itself

Abstract

backgroundAngiogenic dysfunction and abnormalities in psychopathology and brain structure have been reported in schizophrenia, but their relationships are mostly unknown. We recently demonstrated that sFlt-1, anti-angiogenic factor, was significantly elevated in patients at familial high-risk for psychosis (FHR). We hypothesized that elevated sFlt-1 correlates with baseline and longitudinal changes in psychopathology, cognition, and brain structure.

methodsPlasma sFlt-1 in FHR (n=35) and HC (n=39) was obtained at baseline. Schizotypal, cognitive, soft neurologic signs, and structural brain imaging (1.5T T1-weighted MRI, FreeSurfer software) measures were obtained in both groups. Longitudinal clinical and brain structural measures were obtained in a subgroup of FHR patients. Baseline data analysis used correlations between sFlt-1 and clinical/imaging measures and adjusted for multiple corrections. Linear mixed-effects models described differences in trajectories between high sFlt-1 and low sFlt-1.

resultsBaseline sFlt-1 was significantly correlated with soft neurologic signs (r=0.27, p=0.02) and right entorhinal volume (r=0.50, p=0.02), but not other baseline clinical/brain structural measures. Longitudinal examination of the FHR group (sFlt-1 high, n=14; sFlt-1 low, n=14) demonstrated that high sFlt-1 was significantly associated with worsening schizotypal symptoms (t=2.4, p=0.018). Reduced right hippocampal/parahippocampal volume/thickness trajectories were observed in high versus low sFlt-1 groups.

conclusionsThe findings from this FHR study demonstrate that peripheral markers of angiogenic dysfunction can predict longitudinal clinical and brain structural changes. Also, these findings further support the hypothesis of altered microvascular circulation in schizophrenia and those at risk.

Indexed as

AdolescentAdultBrainCognition DisordersFemaleHumansImage Processing, Computer-AssistedLinear ModelsLongitudinal StudiesMagnetic Resonance ImagingMalePsychiatric Status Rating ScalesPsychotic DisordersStatistics as TopicVascular Endothelial Growth Factor Receptor-1Young AdultFLT1 protein, humanVascular Endothelial Growth Factor Receptor-1AngiogenesisBrain structureGenetic high risk for psychosisLongitudinal studyMicrovascularSoluble fms-like tyrosine kinase

Identifiers

PMID27863935
PMCPMC5432401
OpenAlexW2552709834

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.